- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07683962
Influence of Early Wound Healing on the Outcomes of Regenerative Periodontal Surgery (EWH_reg)
June 28, 2026 updated by: Andrea Pilloni MD DDS MS, University of Roma La Sapienza
Influence of Early Wound Healing on the 12-month Clinical and Radiographic Outcomes of Regenerative Periodontal Surgery: a Prospective Observational Cohort Study
This study investigates whether early post-surgical healing (1-2 weeks) affects the 12-month clinical and radiographic success of periodontal regenerative therapy in patients with Stage III-IV periodontitis.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andrea Pilloni
- Phone Number: +39 3356409374
- Email: andrea.pilloni@uniroma1.it
Study Locations
-
-
Rome
-
Rome, Rome, Italy, 00161
- Recruiting
- Sapienza University of Rome, Department of Oral and Maxillofacial Sciences, Section of Periodontology
-
Contact:
- Andrea Pilloni
- Phone Number: +39 3356409374
- Email: andrea.pilloni@uniroma1.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population consists of adult patients (ages 18-75) diagnosed with Stage III or IV Periodontitis according to the 2017 World Workshop Classification.
These patients present with at least one deep interproximal infrabony defect requiring regenerative surgical treatment.
Participants are recruited from the patient pool of the Section of Periodontics at Sapienza University of Rome, Italy.
The population includes both systemically healthy individuals and those with well-controlled systemic conditions (ASA I or II), who have maintained optimal oral hygiene (FMPS/FMBS < 15%) following initial non-surgical periodontal therapy.
Description
Inclusion Criteria:
- Diagnosis of Stage III or IV Periodontitis.
- Presence of at least one deep interproximal infrabony defect (Probing Pocket Depth [PPD] >= mm, radiographic depth >= 3 mm).
- Optimal oral hygiene: Full-Mouth Plaque Score (FMPS) and Full-Mouth Bleeding Score (FMBS) < 15% at the time of surgery.
Exclusion Criteria:
- Systemic: ASA III-VI classification; uncontrolled diabetes; medications causing gingival overgrowth (e.g., nifedipine, cyclosporine, phenytoin); heavy smokers (>10 cigarettes/day); pregnancy or lactation.
- Local: Third molars; Grade III tooth mobility; inadequate endodontic treatment; teeth undergoing orthodontic treatment; teeth supporting removable or implant-linked fixed prosthetics.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Periodontal Regeneration Cohort
his single cohort consists of patients with Stage III-IV periodontitis presenting at least one deep vertical infrabony defect.
All patients receive periodontal regenerative surgery according to clinical indications.
The cohort will be subsequently stratified into subgroups during data analysis based on their Early Wound Healing Index (EHI) scores at 1 and 2 weeks to evaluate the impact of healing quality on 12-month clinical attachment level (CAL) and radiographic outcomes.
|
All subjects undergo surgical debridement of the infrabony defect followed by a regenerative approach (biologics, bone grafts, or blood clot alone) using papilla preservation techniques (MIST, M-MIST, MPPT, SPPF, or SFA).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Clinical Attachment Level (CAL).
Time Frame: Baseline, 6 months, and 12 months.
|
Baseline, 6 months, and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early wound healing Classification
Time Frame: 1 and 2 weeks
|
This system categorizes wounds into Classes (I-III) and Subclasses (A-C).
The Classes define the wound closure status, with Class I indicating complete closure, Class II representing partial closure, and Class III denoting an open wound.
The Subclasses assess the quality of healing by evaluating clinical signs during the hemostatic and inflammatory phase and the proliferative phase.
Subclass A reflects optimal healing, Subclass B indicates sub-optimal healing, and Subclass C describes complicated healing.
|
1 and 2 weeks
|
|
Probing Pocket Depth (PPD) Change:
Time Frame: Baseline, 6 months, and 12 months.
|
Baseline, 6 months, and 12 months.
|
|
|
Early Wound Healing Index (EHI)
Time Frame: 1 and 2 weeks
|
Assessed using the Early Wound Healing Index (EHI) by Wachtel et al.
The index ranges from a minimum score of 1 (complete tissue closure without fibrin) to a maximum score of 5 (incomplete tissue closure with partial/complete necrosis).
Higher scores mean a worse clinical outcome.
|
1 and 2 weeks
|
|
Change in Radiographic Linear Bone Fill
Time Frame: Baseline, 6 months, and 12 months.
|
Measured in millimeters (mm) on standardized radiographs from baseline to 6 and 12 months.
It calculates the distance from a fixed reference point (e.g., cementoenamel junction) to the bottom of the bony defect.
A positive change (increase in mm) indicates bone gain (better outcome).
|
Baseline, 6 months, and 12 months.
|
|
Oral Health Impact Profile-14 questionnaire
Time Frame: 1 and 2 weeks
|
Evaluation of oral health-related quality of life using the unabbreviated Oral Health Impact Profile-14 (OHIP-14) questionnaire.
The total score ranges from a minimum of 0 to a maximum of 56.
Higher scores mean a worse outcome (greater negative impact on quality of life).
|
1 and 2 weeks
|
|
Number of analgesic tablets
Time Frame: 1 and 2 weeks
|
1 and 2 weeks
|
|
|
Patient-Reported Postoperative Swelling as Assessed by a Visual Analog Scale (VAS)
Time Frame: 1 and 2 weeks
|
Postoperative swelling evaluated by the patient using a 100-mm Visual Analog Scale (VAS).
The scale ranges from 0 mm (no swelling) to 100 mm (severe swelling).
Higher scores indicate worse outcomes (greater swelling).
|
1 and 2 weeks
|
|
Percentage of Sites With Bleeding on Probing (BOP)
Time Frame: Baseline, 6 months and 12 months
|
Presence or absence of bleeding assessed within 30 seconds of probing at specific sites.
The data will be aggregated and reported as the percentage of sites showing bleeding out of the total sites examined.
Higher percentages indicate worse outcomes.
|
Baseline, 6 months and 12 months
|
|
Postoperative Pain/Discomfort as Assessed by a Visual Analog Scale (VAS)
Time Frame: 1 and 2 weeks
|
Patient's self-reported surgical discomfort/pain measured using a 100-mm Visual Analog Scale (VAS).
The scale ranges from 0 mm (no pain/discomfort) to 100 mm (worst possible pain).
Higher scores indicate worse outcomes.
|
1 and 2 weeks
|
|
Patient-Reported Postoperative Estethics as Assessed by a Visual Analog Scale (VAS)
Time Frame: 1 and 2 weeks
|
Patient's self-reported estethics measured using a 100-mm Visual Analog Scale (VAS).
The scale ranges from 0 mm (worst possible estethics) to 100 mm (better possible estethics).
Higher scores indicate better outcomes.
|
1 and 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Study Registration Dates
First Submitted
May 7, 2026
First Submitted That Met QC Criteria
June 28, 2026
First Posted (Actual)
July 6, 2026
Study Record Updates
Last Update Posted (Actual)
July 6, 2026
Last Update Submitted That Met QC Criteria
June 28, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 8328
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Healing
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Ursula WerraUniversitätsklinikum Hamburg-Eppendorf; neoplas med GmbHNot yet recruitingWound Healing | Prevention | Wound Healing Complication | Peripheral Occlusive Disease | Cold Atmospheric PlasmaGermany
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingWound Healing
-
Inonu UniversityCompletedWound HealingTurkey (Türkiye)
-
Pakistan Institute of Medical SciencesNot yet recruitingWound Healing | Wound Infection Post-Traumatic
-
Saglik Bilimleri UniversitesiCompletedWound Healing | Tooth Extraction Site HealingTurkey (Türkiye)
-
Peking University Third HospitalRecruitingWound Heal | Wound Healing DelayedChina
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingWound Healing
-
Universidad Complutense de MadridRecruitingGingival Vascularization | Oral Soft Tissue Wound Healing | Laser Speckle Contrast Imaging | Periodontal Wound HealingSpain
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingWound Healing
Clinical Trials on Periodontal Regenerative Therapy
-
University Hospital MuensterdfgRecruitingPeriodontitis | PeriimplantitisGermany
-
University of Santiago de CompostelaActive, not recruitingRegeneration | Periodontal Defects | BiomaterialsSpain
-
Akdeniz UniversityCompletedPeriodontitisTurkey (Türkiye)
-
Tanta UniversityActive, not recruitingLocalized Aggressive PeriodontitisEgypt
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
Postgraduate Institute of Dental Sciences RohtakUnknown
-
University of ValenciaRegedent AG, ZürichCompletedChronic Periodontitis | Periodontal Bone LossSpain
-
Medical University of WarsawRecruitingPeriodontitis | RegenerationPoland
-
Shashi DadlaniNot yet recruitingPeriodontal Bone Loss | Periodontal Defect | Periodontitis Stage III | Periodontitis Stage IV